# Extended-release Naltrexone for Alcohol Dependence in Primary Care

> **NCT00620750** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 72 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** Extended release injectable naltrexone (Vivitrol)

## Key facts

- **NCT ID:** NCT00620750
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-11
- **Final completion:** 2010-02
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2011-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00620750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00620750, "Extended-release Naltrexone for Alcohol Dependence in Primary Care". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00620750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*